Article
Small-molecule modulation of Ras signaling.
Nature chemical biology - 1 Aug 2014
Spiegel Jochen, Cromm Philipp M, Zimmermann Gunther, Grossmann Tom N, Waldmann Herbert
Abstract excerpt
Despite intense efforts in pharmaceutical industry and academia, a therapeutic grip on oncogenic Ras proteins has remained elusive. Mutated Ras is associated with ~20-30% of all human cancers often not responsive to established therapies. In particular, K-Ras, the most frequently mutated Ras isoform, is considered one of the most important but 'undruggable' targets in cancer research. Recently, new cavities on...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
